{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:52:26Z","timestamp":1793137946332,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004100","name":"Laboratoire d'Excellence (LabEx) ParaFrap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["614880 Hosting TOXO"],"award-info":[{"award-number":["614880 Hosting TOXO"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR\u201011\u2010LABX\u20100024"],"award-info":[{"award-number":["ANR\u201011\u2010LABX\u20100024"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR\u201012\u2010BSV3\u20100009\u201001"],"award-info":[{"award-number":["ANR\u201012\u2010BSV3\u20100009\u201001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR\u201012\u2010JSV3\u20100004\u201001"],"award-info":[{"award-number":["ANR\u201012\u2010JSV3\u20100004\u201001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2017,3,1]]},"DOI":"10.15252\/emmm.201607370","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T20:10:14Z","timestamp":1485979814000},"page":"385-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-319X","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Palencia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-0020","authenticated-orcid":false,"given":"Alexandre","family":"Bougdour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie\u2010Pierre","family":"Brenier\u2010Pinchart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Touquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose\u2010Laurence","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vollaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Josserand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Easom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne R","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Pelloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Cusack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-8233","authenticated-orcid":false,"given":"Mohamed\u2010Ali","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"key":"BFEMMM201607370_CR1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1124\/jpet.113.207662","volume":"347","author":"T Akama","year":"2013","unstructured":"Akama T, Dong C, Virtucio C, Sullivan D, Zhou Y, Zhang Y\u2010K, Rock F, Freund Y, Liu L, Bu W et\u00a0al (2013) Linking phenotype to kinase: identification of a novel benzoxaborole hinge\u2010binding motif for kinase inhibition and development of high\u2010potency rho kinase inhibitors. J Pharmacol Exp Ther 347: 615\u2013625","journal-title":"J Pharmacol Exp Ther"},{"key":"BFEMMM201607370_CR2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4155\/fmc.09.71","volume":"1","author":"SJ Baker","year":"2009","unstructured":"Baker SJ, Ding CZ, Akama T, Zhang Y\u2010K, Hernandez V, Xia Y (2009) Therapeutic potential of boron\u2010containing compounds. Future Med Chem 1: 1275\u20131288","journal-title":"Future Med Chem"},{"key":"BFEMMM201607370_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.chom.2013.03.002","volume":"13","author":"A Bougdour","year":"2013","unstructured":"Bougdour A, Durandau E, Brenier\u2010Pinchart M\u2010P, Ortet P, Barakat M, Kieffer S, Curt\u2010Varesano A, Curt\u2010Bertini R\u2010L, Bastien O, Coute Y et\u00a0al (2013) Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. Cell Host Microbe 13: 489\u2013500","journal-title":"Cell Host Microbe"},{"key":"BFEMMM201607370_CR4","first-page":"e3807","volume":"60","author":"BI Coleman","year":"2012","unstructured":"Coleman BI, Gubbels M\u2010J (2012) A genetic screen to isolate Toxoplasma gondii host\u2010cell egress mutants. J Vis Exp 60: e3807","journal-title":"J Vis Exp"},{"key":"BFEMMM201607370_CR5","first-page":"68","volume":"54","author":"M Crespo","year":"2000","unstructured":"Crespo M, Quereda C, Pascual J, Rivera M, Clemente L, Cano T (2000) Patterns of sulfadiazine acute nephrotoxicity. Clin Nephrol 54: 68\u201372","journal-title":"Clin Nephrol"},{"key":"BFEMMM201607370_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cmi.12498","volume":"18","author":"A Curt\u2010Varesano","year":"2016","unstructured":"Curt\u2010Varesano A, Braun L, Ranquet C, Hakimi M\u2010A, Bougdour A (2016) The aspartyl protease TgASP5 mediates the export of the Toxoplasma GRA16 and GRA24 effectors into host cells: TgASP5 is essential for GRA16 and GRA24 export. Cell Microbiol 18: 151\u2013167","journal-title":"Cell Microbiol"},{"key":"BFEMMM201607370_CR7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/MCB.25.4.1489-1500.2005","volume":"25","author":"Z Dominski","year":"2005","unstructured":"Dominski Z, Yang X\u2010C, Purdy M, Wagner EJ, Marzluff WF (2005) A CPSF\u201073 homologue is required for cell cycle progression but not cell growth and interacts with a protein having features of CPSF\u2010100. Mol Cell Biol 25: 1489\u20131500","journal-title":"Mol Cell Biol"},{"key":"BFEMMM201607370_CR8","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K (2004) Coot: model\u2010building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126\u20132132","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFEMMM201607370_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/1471-2164-15-354","volume":"15","author":"A Farrell","year":"2014","unstructured":"Farrell A, Coleman BI, Benenati B, Brown KM, Blader IJ, Marth GT, Gubbels M\u2010J (2014) Whole genome profiling of spontaneous and chemically induced mutations in Toxoplasma gondii. BMC Genom 15: 354","journal-title":"BMC Genom"},{"key":"BFEMMM201607370_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0140-6736(92)90132-M","volume":"339","author":"C Farthing","year":"1992","unstructured":"Farthing C, Rendel M, Currie B, Seidlin M (1992) Azithromycin for cerebral toxoplasmosis. Lancet 339: 437\u2013438","journal-title":"Lancet"},{"key":"BFEMMM201607370_CR11","doi-asserted-by":"crossref","first-page":"e90203","DOI":"10.1371\/journal.pone.0090203","volume":"9","author":"J Flegr","year":"2014","unstructured":"Flegr J, Prandota J, Sovi\u010dkov\u00e1 M, Israili ZH (2014) Toxoplasmosis \u2013 a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One 9: e90203","journal-title":"PLoS One"},{"key":"BFEMMM201607370_CR12","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1016\/j.febslet.2012.07.058","volume":"586","author":"YR Freund","year":"2012","unstructured":"Freund YR, Akama T, Alley MRK, Antunes J, Dong C, Jarnagin K, Kimura R, Nieman JA, Maples KR, Plattner JJ et\u00a0al (2012) Boron\u2010based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center. FEBS Lett 586: 3410\u20133414","journal-title":"FEBS Lett"},{"key":"BFEMMM201607370_CR13","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2010ligand complexes. J Med Chem 49: 6177\u20136196","journal-title":"J Med Chem"},{"key":"BFEMMM201607370_CR14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0149-2918(96)80059-2","volume":"18","author":"HB Fung","year":"1996","unstructured":"Fung HB, Kirschenbaum HL (1996) Treatment regimens for patients with toxoplasmic encephalitis. Clin Ther 18: 1037\u20131056; discussion 1036","journal-title":"Clin Ther"},{"key":"BFEMMM201607370_CR15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1128\/AAC.02058-12","volume":"57","author":"V Hernandez","year":"2013","unstructured":"Hernandez V, Cr\u00e9pin T, Palencia A, Cusack S, Akama T, Baker SJ, Bu W, Feng L, Freund YR, Liu L et\u00a0al (2013) Discovery of a novel class of boron\u2010based antibacterials with activity against gram\u2010negative bacteria. Antimicrob Agents Chemother 57: 1394\u20131403","journal-title":"Antimicrob Agents Chemother"},{"key":"BFEMMM201607370_CR16","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1016\/j.bmc.2014.04.065","volume":"22","author":"CT Liu","year":"2014","unstructured":"Liu CT, Tomsho JW, Benkovic SJ (2014) The unique chemistry of benzoxaboroles: current and emerging applications in biotechnology and therapeutic treatments. Bioorg Med Chem 22: 4462\u20134473","journal-title":"Bioorg Med Chem"},{"key":"BFEMMM201607370_CR17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nature05363","volume":"444","author":"CR Mandel","year":"2006","unstructured":"Mandel CR, Kaneko S, Zhang H, Gebauer D, Vethantham V, Manley JL, Tong L (2006) Polyadenylation factor CPSF\u201073 is the pre\u2010mRNA 3\u2032\u2010end\u2010processing endonuclease. Nature 444: 953\u2013956","journal-title":"Nature"},{"key":"BFEMMM201607370_CR18","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","volume":"59","author":"AJ Neville","year":"2015","unstructured":"Neville AJ, Zach SJ, Wang X, Larson JJ, Judge AK, Davis LA, Vennerstrom JL, Davis PH (2015) Clinically available medicines demonstrating anti\u2010Toxoplasma activity. Antimicrob Agents Chemother 59: 7161\u20137169","journal-title":"Antimicrob Agents Chemother"},{"key":"BFEMMM201607370_CR19","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1128\/AAC.01339-16","volume":"60","author":"A Palencia","year":"2016","unstructured":"Palencia A, Li X, Bu W, Choi W, Ding CZ, Easom EE, Feng L, Hernandez V, Houston P, Liu L et\u00a0al (2016b) Discovery of novel oral protein synthesis inhibitors of Mycobacterium tuberculosis that target leucyl\u2010tRNA synthetase. Antimicrob Agents Chemother 60: 6271\u20136280","journal-title":"Antimicrob Agents Chemother"},{"key":"BFEMMM201607370_CR20","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/AAC.00873-16","volume":"60","author":"A Palencia","year":"2016","unstructured":"Palencia A, Liu R\u2010J, Lukarska M, Gut J, Bougdour A, Touquet B, Wang E\u2010D, Li X, Alley MRK, Freund YR et\u00a0al (2016a) Cryptosporidium and Toxoplasma parasites are inhibited by a benzoxaborole targeting leucyl\u2010tRNA synthetase. Antimicrob Agents Chemother 60: 5817\u20135827","journal-title":"Antimicrob Agents Chemother"},{"key":"BFEMMM201607370_CR21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas G, Roussos N, Falagas ME (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39: 1385\u20131394","journal-title":"Int J Parasitol"},{"key":"BFEMMM201607370_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/pim.12157","volume":"37","author":"A Parlog","year":"2015","unstructured":"Parlog A, Schl\u00fcter D, Dunay IR (2015) Toxoplasma gondii\u2010induced neuronal alterations. Parasite Immunol 37: 159\u2013170","journal-title":"Parasite Immunol"},{"key":"BFEMMM201607370_CR23","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","volume":"316","author":"FL Rock","year":"2007","unstructured":"Rock FL, Mao W, Yaremchuk A, Tukalo M, Cr\u00e9pin T, Zhou H, Zhang Y\u2010K, Hernandez V, Akama T, Baker SJ et\u00a0al (2007) An antifungal agent inhibits an aminoacyl\u2010tRNA synthetase by trapping tRNA in the editing site. Science 316: 1759\u20131761","journal-title":"Science"},{"key":"BFEMMM201607370_CR24","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.37.11.2371","volume":"37","author":"S Romand","year":"1993","unstructured":"Romand S, Pudney M, Derouin F (1993) In vitro and in\u00a0vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrob Agents Chemother 37: 2371\u20132378","journal-title":"Antimicrob Agents Chemother"},{"key":"BFEMMM201607370_CR25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1261\/rna.5214404","volume":"10","author":"K Ryan","year":"2004","unstructured":"Ryan K, Calvo O, Manley JL (2004) Evidence that polyadenylation factor CPSF\u201073 is the mRNA 3\u2032 processing endonuclease. RNA 10: 565\u2013573","journal-title":"RNA"},{"key":"BFEMMM201607370_CR26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid1701.P11101","volume":"17","author":"E Scallan","year":"2011","unstructured":"Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M\u2010A, Roy SL, Jones JL, Griffin PM (2011) Foodborne illness acquired in the United States\u2013major pathogens. Emerg Infect Dis 17: 7\u201315","journal-title":"Emerg Infect Dis"},{"key":"BFEMMM201607370_CR27","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1101\/gad.250985.114","volume":"28","author":"L Sch\u00f6nemann","year":"2014","unstructured":"Sch\u00f6nemann L, K\u00fchn U, Martin G, Sch\u00e4fer P, Gruber AR, Keller W, Zavolan M, Wahle E (2014) Reconstitution of CPSF active in polyadenylation: recognition of the polyadenylation signal by WDR33. Genes Dev 28: 2381\u20132393","journal-title":"Genes Dev"},{"key":"BFEMMM201607370_CR28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.micro.62.081307.162925","volume":"62","author":"LD Sibley","year":"2008","unstructured":"Sibley LD, Ajioka JW (2008) Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu Rev Microbiol 62: 329\u2013351","journal-title":"Annu Rev Microbiol"},{"key":"BFEMMM201607370_CR29","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.cell.2016.08.019","volume":"166","author":"SM Sidik","year":"2016","unstructured":"Sidik SM, Huet D, Ganesan SM, Huynh M\u2010H, Wang T, Nasamu AS, Thiru P, Saeij JPJ, Carruthers VB, Niles JC et\u00a0al (2016) A genome\u2010wide CRISPR screen in Toxoplasma identifies essential apicomplexan genes. Cell 166: 1423\u20131435.e12","journal-title":"Cell"},{"key":"BFEMMM201607370_CR300","doi-asserted-by":"crossref","unstructured":"Sonoiki E, Ng CL, Lee MCS, Guo D, Zhang Y\u2010K, Zhou Y, Alley MRK, Ahyong V, Sanz\u2010Alonso LM, Monasterio MJL et al (2017) A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue. Nat Commun in press","DOI":"10.1038\/ncomms14574"},{"key":"BFEMMM201607370_CR30","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.bmcl.2011.02.024","volume":"21","author":"Y Xia","year":"2011","unstructured":"Xia Y, Cao K, Zhou Y, Alley MRK, Rock F, Mohan M, Meewan M, Baker SJ, Lux S, Ding CZ et\u00a0al (2011) Synthesis and SAR of novel benzoxaboroles as a new class of \u03b2\u2010lactamase inhibitors. Bioorg Med Chem Lett 21: 2533\u20132536","journal-title":"Bioorg Med Chem Lett"},{"key":"BFEMMM201607370_CR31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1128\/MCB.00084-14","volume":"34","author":"K Xiang","year":"2014","unstructured":"Xiang K, Tong L, Manley JL (2014) Delineating the structural blueprint of the Pre\u2010mRNA 3\u2032\u2010end processing machinery. Mol Cell Biol 34: 1894\u20131910","journal-title":"Mol Cell Biol"},{"key":"BFEMMM201607370_CR32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y (2008) I\u2010TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40","journal-title":"BMC Bioinformatics"},{"key":"BFEMMM201607370_CR33","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1039\/c3ob40236c","volume":"11","author":"F Zhang","year":"2013","unstructured":"Zhang F, Du J, Wang Q, Hu Q, Zhang J, Ding D, Zhao Y, Yang F, Wang E, Zhou H (2013) Discovery of N\u2010(4\u2010sulfamoylphenyl)thioureas as Trypanosoma brucei leucyl\u2010tRNA synthetase inhibitors. Org Biomol Chem 11: 5310\u20135324","journal-title":"Org Biomol Chem"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201607370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201607370","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201607370\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201607370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201607370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:19:04Z","timestamp":1779085144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201607370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3,1]]}},"alternative-id":["BFEMMM201607370"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201607370","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]},"assertion":[{"value":"22 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.E. and Y.R.F. are employees of Anacor Pharmaceuticals, Inc. The other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}